366 related articles for article (PubMed ID: 32226530)
1. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
[No Abstract] [Full Text] [Related]
2. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
3. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
[TBL] [Abstract][Full Text] [Related]
6. The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer.
Arai H; Elliott A; Xiu J; Wang J; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Sohal D; Goldberg RM; Hall MJ; Scott AJ; Khushman M; Hwang JJ; Lou E; Weinberg BA; Marshall JL; Lockhart AC; Stafford P; Zhang J; Moretto R; Cremolini C; Korn WM; Lenz HJ
Clin Cancer Res; 2021 Jun; 27(11):3234-3242. PubMed ID: 33766816
[TBL] [Abstract][Full Text] [Related]
7. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B
DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757
[TBL] [Abstract][Full Text] [Related]
8. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.
Ding K; He Y; Wei J; Fu S; Wang J; Chen Z; Zhang H; Qu Y; Liang K; Gong X; Qiu L; Chen D; Xiao B; Du H
Front Immunol; 2022; 13():943090. PubMed ID: 36081518
[TBL] [Abstract][Full Text] [Related]
9. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
[TBL] [Abstract][Full Text] [Related]
10. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
[TBL] [Abstract][Full Text] [Related]
11. Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.
Lou S; Wang Y; Zhang J; Yin X; Zhang Y; Wang Y; Xue Y
Front Immunol; 2021; 12():806324. PubMed ID: 35082793
[TBL] [Abstract][Full Text] [Related]
12. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
13. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
[TBL] [Abstract][Full Text] [Related]
14. DNA damage response regulation by microRNAs as a therapeutic target in cancer.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Nov; 47():1-11. PubMed ID: 27697364
[TBL] [Abstract][Full Text] [Related]
15. Targeting the DNA Damage Response in Cancer.
O'Connor MJ
Mol Cell; 2015 Nov; 60(4):547-60. PubMed ID: 26590714
[TBL] [Abstract][Full Text] [Related]
16. DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.
Esposito MT; So CW
Chromosoma; 2014 Dec; 123(6):545-61. PubMed ID: 25112726
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer.
Yin M; Grivas P; Wang QE; Mortazavi A; Emamekhoo H; Holder SL; Drabick JJ; Woo MS; Pal S; Vasekar M; Folefac E; Clinton SK; Monk P; Joshi M
Oncologist; 2020 Aug; 25(8):680-688. PubMed ID: 32275806
[TBL] [Abstract][Full Text] [Related]
18. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
[TBL] [Abstract][Full Text] [Related]
19. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
Bottai G; Pasculli B; Calin GA; Santarpia L
Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
[TBL] [Abstract][Full Text] [Related]
20. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
